b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2831817/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831817/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Biotechnology" /><meta name="citation_title" content="High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli" /><meta name="citation_authors" content="Huiyan Wang, Yechen Xiao, Lianjun Fu, Hongxin Zhao, Yaofang Zhang, Xiaoshan Wan, Yuxia Qin, Yadong Huang, Hongchang Gao, Xiaokun Li" /><meta name="citation_date" content="2010" /><meta name="citation_volume" content="10" /><meta name="citation_doi" content="10.1186/1472-6750-10-14" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2831817/?report=abstract" /><meta name="citation_pmid" content="20163718" /><meta name="DC.Title" content="High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Huiyan Wang" /><meta name="DC.Contributor" content="Yechen Xiao" /><meta name="DC.Contributor" content="Lianjun Fu" /><meta name="DC.Contributor" content="Hongxin Zhao" /><meta name="DC.Contributor" content="Yaofang Zhang" /><meta name="DC.Contributor" content="Xiaoshan Wan" /><meta name="DC.Contributor" content="Yuxia Qin" /><meta name="DC.Contributor" content="Yadong Huang" /><meta name="DC.Contributor" content="Hongchang Gao" /><meta name="DC.Contributor" content="Xiaokun Li" /><meta name="DC.Date" content="2010" /><meta name="DC.Identifier" content="10.1186/1472-6750-10-14" /><meta name="DC.Language" content="en" /><meta property="og:title" content="High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli" /><meta property="og:type" content="article" /><meta property="og:description" content="Fibroblast growth factor 21 (FGF21) is a promising drug candidate to combat metabolic diseases. However, high-level expression and purification of recombinant FGF21 (rFGF21) in Escherichia coli (E. coli) is difficult because rFGF21 forms inclusion bodies ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831817/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2831817/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2831817/pdf/12896_2009_Article_482.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B943DE9A435B100000000037B037B.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2831817</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">BMC Biotechnology</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Biotechnol</span>. 2010; 10: 14. </span></div><div><span class="fm-vol-iss-date">Published online 2010 Feb 17. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1472-6750-10-14" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1472-6750-10-14</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2831817</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20163718">20163718</a></div></div></div></div><h1 class="content-title">High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in <em>Escherichia coli</em></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Wang%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727982722368" co-class="co-affbox">Huiyan Wang</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Xiao%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727984830976" co-class="co-affbox">Yechen Xiao</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>#</sup><sup>1</sup> <a href="/pubmed/?term=Fu%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727984828800" co-class="co-affbox">Lianjun Fu</a>,<sup>3</sup> <a href="/pubmed/?term=Zhao%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727983048352" co-class="co-affbox">Hongxin Zhao</a>,<sup>1</sup> <a href="/pubmed/?term=Zhang%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727983046432" co-class="co-affbox">Yaofang Zhang</a>,<sup>1</sup> <a href="/pubmed/?term=Wan%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727983044064" co-class="co-affbox">Xiaoshan Wan</a>,<sup>1</sup> <a href="/pubmed/?term=Qin%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727983041696" co-class="co-affbox">Yuxia Qin</a>,<sup>1</sup> <a href="/pubmed/?term=Huang%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727983039328" co-class="co-affbox">Yadong Huang</a>,<sup>4</sup> <a href="/pubmed/?term=Gao%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727983036960" co-class="co-affbox">Hongchang Gao</a>,<sup>2</sup> and  <a href="/pubmed/?term=Li%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718" class="affpopup" co-rid="_co_idm139727983034592" co-class="co-affbox">Xiaokun Li</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139727982722368"><h3 class="no_margin">Huiyan Wang</h3><p><sup>1</sup>Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University, 130118 China </p><p><sup>2</sup>School of Pharmacy, Wenzhou Medical College, Wenzhou, Zhejiang 325000 China </p><div>Find articles by <a href="/pubmed/?term=Wang%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Huiyan Wang</a></div></div><div id="_co_idm139727984830976"><h3 class="no_margin">Yechen Xiao</h3><p><sup>1</sup>Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University, 130118 China </p><div>Find articles by <a href="/pubmed/?term=Xiao%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Yechen Xiao</a></div></div><div id="_co_idm139727984828800"><h3 class="no_margin">Lianjun Fu</h3><p><sup>3</sup>Jilin Agricultural Science and Technology College, 132101 China </p><div>Find articles by <a href="/pubmed/?term=Fu%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Lianjun Fu</a></div></div><div id="_co_idm139727983048352"><h3 class="no_margin">Hongxin Zhao</h3><p><sup>1</sup>Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University, 130118 China </p><div>Find articles by <a href="/pubmed/?term=Zhao%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Hongxin Zhao</a></div></div><div id="_co_idm139727983046432"><h3 class="no_margin">Yaofang Zhang</h3><p><sup>1</sup>Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University, 130118 China </p><div>Find articles by <a href="/pubmed/?term=Zhang%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Yaofang Zhang</a></div></div><div id="_co_idm139727983044064"><h3 class="no_margin">Xiaoshan Wan</h3><p><sup>1</sup>Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University, 130118 China </p><div>Find articles by <a href="/pubmed/?term=Wan%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Xiaoshan Wan</a></div></div><div id="_co_idm139727983041696"><h3 class="no_margin">Yuxia Qin</h3><p><sup>1</sup>Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University, 130118 China </p><div>Find articles by <a href="/pubmed/?term=Qin%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Yuxia Qin</a></div></div><div id="_co_idm139727983039328"><h3 class="no_margin">Yadong Huang</h3><p><sup>4</sup>Biopharmaceutical research and Development Center, Institute of Life and Health Engineering, Jinan University, Guangzhou, 510642 China </p><div>Find articles by <a href="/pubmed/?term=Huang%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Yadong Huang</a></div></div><div id="_co_idm139727983036960"><h3 class="no_margin">Hongchang Gao</h3><p><sup>2</sup>School of Pharmacy, Wenzhou Medical College, Wenzhou, Zhejiang 325000 China </p><div>Find articles by <a href="/pubmed/?term=Gao%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Hongchang Gao</a></div></div><div id="_co_idm139727983034592"><h3 class="no_margin">Xiaokun Li</h3><p><sup>1</sup>Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University, 130118 China </p><div>Find articles by <a href="/pubmed/?term=Li%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20163718">Xiaokun Li</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139728024756000_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139728024756000_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139728024756000_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139728024756000_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University, 130118 China </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>School of Pharmacy, Wenzhou Medical College, Wenzhou, Zhejiang 325000 China </div><div class="fm-affl" lang="en" id="Aff3"><sup>3</sup>Jilin Agricultural Science and Technology College, 132101 China </div><div class="fm-affl" lang="en" id="Aff4"><sup>4</sup>Biopharmaceutical research and Development Center, Institute of Life and Health Engineering, Jinan University, Guangzhou, 510642 China </div><div><span class="fm-affl">Huiyan Wang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.oohay@nayiuh_w" class="oemail">nc.moc.oohay@nayiuh_w</a></span>.</div><div><a href="#idm139728024756000aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139728024756000_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Aug 13; Accepted 2010 Feb 17.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139728024756000_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Wang et al; licensee BioMed Central Ltd. 2010</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2831817/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Fibroblast growth factor 21 (FGF21) is a promising drug candidate to combat metabolic diseases. However, high-level expression and purification of recombinant FGF21 (rFGF21) in <em>Escherichia coli (E. coli)</em> is difficult because rFGF21 forms inclusion bodies in the bacteria making it difficult to purify and obtain high concentrations of bioactive rFGF21. To overcome this problem, we fused the <em>FGF21</em> with <em>SUMO</em> (Small ubiquitin-related modifier) by polymerase chain reaction (PCR), and expressed the fused gene in <em>E. coli</em> BL21(DE3).</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Results</h3><p id="__p2" class="p p-first-last">By inducing with IPTG, SUMO-FGF21 was expressed at a high level. Its concentration reached 30% of total protein, and exceeded 95% of all soluble proteins. The fused protein was purified by DEAE sepharose FF and Ni-NTA affinity chromatography. Once cleaved by the SUMO protease, the purity of rFGF21 by high performance liquid chromatography (HPLC) was shown to be higher than 96% with low endotoxin level (&#x0003c;1.0 EU/ml). The results of <em>in vivo</em> animal experiments showed that rFGF21 produced by using this method, could decrease the concentration of plasma glucose in diabetic rats by streptozotocin (STZ) injection.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Conclusions</h3><p id="__p3" class="p p-first-last">This study demonstrated that SUMO, when fused with FGF21, was able to promote its soluble expression of the latter in <em>E. coli</em>, making it more convenient to purify rFGF21 than previously. This may be a better method to produce rFGF21 for pharmaceutical research and development.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Electronic supplementary material</h3><p id="__p4" class="p p-first-last">The online version of this article (doi:10.1186/1472-6750-10-14) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">High Performance Liquid Chromatography, Soluble Expression, Form Inclusion Body, Sumo Protease, Human FGF21</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p5" class="p p-first">FGF21 is a potent regulator of glucose homeostasis [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014409">1</a>]. It was originally identified as a hormone that stimulates glucose uptake in adipocytes [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014462">2</a>]. FGF21 is induced and secreted from the liver upon fasting and acts on adipose tissues to induce metabolic adaptation to fasting[<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014413">3</a>, <a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014466">4</a>]. Specifically, FGF21 stimulates lipolysis in adipocytes, a process which releases fatty acids into the bloodstream; when they reach the liver, these fatty acids are converted to ketones[<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014422">3</a>]. FGF21 is free of the proliferative and tumorigenic effects [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014432">5</a>&#x02013;<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014423">7</a>] that are documented for other members of the FGF family [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014421">3</a>, <a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014450">8</a>, <a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014439">9</a>]. Systemic administration of FGF21 reduced plasma glucose, fructosamine, triglycerides, insulin, and glucagon in diabetic rhesus monkeys[<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014424">10</a>]. FGF21 administration led to significant improvements in lipoprotein profiles, by lowering low-density cholesterol and by raising high-density cholesterol, as well as causing weight loss in the animals [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014407">10</a>].</p><p id="__p6">In recent years, FGF21 has been described as potential new drug candidate to combat metabolic diseases [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014434">5</a>, <a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014449">6</a>]. However, producing FGF21 by traditional techniques, such as plasmid recombination in <em>E. coli</em>, yields disappointing results. Kharitonenkov\'s experiment has shown that recombinant FGF21 (rFGF21) accumulated and formed inclusion bodies in transformed <em>E. coli</em> [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014459">5</a>]. Our previous experiments also showed that rFGF21 without fusion expression more easily formed inclusion bodies, and it was difficult to produce bioactive protein (data not shown), because the inclusion bodies need to be denatured, annealed, and purified through many chromatography columns.</p><p id="__p7">SUMO (Small ubiquitin-related modifier) proteins are covalently attached to and removed from specific protein substrates in eukaryotic cells[<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014429">11</a>]. Sumoylation as a reversible post-translational modification process has been shown to be involved in many cellular processes including nuclear-cytosolic transport, apoptosis, protein activation, protein stability, stress response, and cell cycle progression[<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014441">11</a>, <a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014433">12</a>]. In recent years, SUMO has become an effective biotechnological tool as a fusion system to enhance soluble expression of proteins and decrease proteolytic degradation, which could not be achieved by traditional expression systems[<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014411">13</a>, <a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014451">14</a>]. SUMO is then post-translationally enzymatically cleaved from the desired protein by SUMO C-terminal hydrolases-isopeptidases [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014436">13</a>]. Proteins such as, SARS virus protein[<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014427">15</a>], MMP13[<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014453">16</a>], EGF[<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014415">17</a>], metallothionein[<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014447">18</a>], and KGF2[<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014464">19</a>] have been successfully expressed and purified using this fusion strategy.</p><p id="__p8" class="p p-last">Recently, Ren [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014419">20</a>] expressed FGF21 using a commercial vector containing a SUMO tag and showed that SUMO promotes the soluble expression of FGF21 in <em>E. coli</em>. However, no higher level of purity was attained using Ni-NTA affility purification alone. Thus, we cloned SUMO fragment and constructed an expression plasmid containing SUMO and human FGF21. The results show that this novel method of protein expression can promote significantly higher rFGF21 levels, making it easier to be dissolved in the soluble fraction for purification and producing native N-terminal recombinant protein with its bioactivity preserved.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results and discussion</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Synthesis of the fusion gene and construction of pET-SUMO-FGF21 expression vector</h3><p id="__p9" class="p p-first">To synthesize the fusion gene composed of SUMO and FGF21, fourteen special primers were designed (Table <a href="/pmc/articles/PMC2831817/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). The synthesis strategy is described in the Figure <a href="/pmc/articles/PMC2831817/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1</span></span><span>1</span></a> and the detailed procedure is included in <em>Materials and Methods</em>. The PCR products of SUMO-FGF21 are shown in Figure <a href="/pmc/articles/PMC2831817/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure2.</span></span><span>2</span></a>. The final PCR product was digested with two restriction enzymes (<em>Nde</em>I and <em>Xho</em>I) and cloned into the expression vector pET-20b(+). The sequence of the recombinant plasmid was confirmed by automated DNA sequencing. The results show that the sequence of the SUMO-FGF21 (864 bp, SUMO 318 bp, human FGF21 546 bp) is in conformity with the prior sequence. The sequence of the SUMO-FGF21 has been submitted the GenBank database (accession number: <a id="__tag_844014501" class="tag_hotlink" href="/nuccore/GU456634" ref="/nuccore/GU456634"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"GU456634","term_id":"289586383","term_text":"GU456634"}}</span>GU456634</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2831817/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139727985966592" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig1_HTML.jpg" src="/pmc/articles/PMC2831817/bin/12896_2009_Article_482_Fig1_HTML.jpg" /></div><div id="largeobj_idm139727985966592" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2831817/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2831817/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p10"><strong>Schematic illustration of SUMO-FGF21 synthesis</strong>. According to the human FGF21 mRNA coding sequence and the SUMO fragment C-terminal sequence, 21 primers were designed and synthesized. As shown in Figure 1, the SUMO-FGF21 was synthesized by primer extension and PCR. The detailed steps are reported in <em>Material and Methods</em>.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2831817/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139727985962688" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig2_HTML.jpg" src="/pmc/articles/PMC2831817/bin/12896_2009_Article_482_Fig2_HTML.jpg" /></div><div id="largeobj_idm139727985962688" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2831817/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2831817/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p11"><strong>Synthesis of SUMO-FGF21 by PCR</strong>. The strategy for synthesizing the fusion fragment is described in <em>Materials and Methods</em>. The molecular weight of the PCR fragment containing SUMO-FGF21 is shown in Lane 1, 2 and 3. It is 864 bp in length.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p12">PCR primers for amplifying the SUMO-FGF21 fusion gene</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139727985106192" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Primer name (size)</th><th align="left" rowspan="1" colspan="1">Sequence (5\'- 3)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Pa(32 bp)</td><td align="left" rowspan="1" colspan="1">ggaattccatatgcatcatcatcatcatcacg</td></tr><tr><td align="left" rowspan="1" colspan="1">Sumo linker(39 bp)</td><td align="left" rowspan="1" colspan="1">tggagtcagggatggggtgaccaccaatctgttctctgt</td></tr><tr><td align="left" rowspan="1" colspan="1">P1(59 bp)</td><td align="left" rowspan="1" colspan="1">gccggatccatgcaccccatccctgactccagtcctctcctgcaattcgggggccaagt</td></tr><tr><td align="left" rowspan="1" colspan="1">P2(59 bp)</td><td align="left" rowspan="1" colspan="1">ctgtctgctgggcatcatctgtgtagaggtaccgctgccggacttgcccccg aattgc</td></tr><tr><td align="left" rowspan="1" colspan="1">P3(59 bp)</td><td align="left" rowspan="1" colspan="1">gatgatgcccagcagacagaagcccacctggagatcagggaggatgggacggtgggggg</td></tr><tr><td align="left" rowspan="1" colspan="1">P4(59 bp)</td><td align="left" rowspan="1" colspan="1">tttcagctgcaggagactttcggggctctggtcagcagcgccccccaccgtcccatcct</td></tr><tr><td align="left" rowspan="1" colspan="1">P5(59 bp)</td><td align="left" rowspan="1" colspan="1">aagtctcctgcagctgaaagccttgaagccgggagttattcaaatcttgggagtcaaga</td></tr><tr><td align="left" rowspan="1" colspan="1">P6(59 bp)</td><td align="left" rowspan="1" colspan="1">tacagggccccatctggccgctggcacaggaacctggatgtcttgactcccaagatttg</td></tr><tr><td align="left" rowspan="1" colspan="1">P7(59 bp)</td><td align="left" rowspan="1" colspan="1">ggccagatggggccctgtatggatcgctccactttgaccctgaggcctgcagcttccgg</td></tr><tr><td align="left" rowspan="1" colspan="1">P8(59 bp)</td><td align="left" rowspan="1" colspan="1">cggactggtaaacattgtatccgtcctcaagaagcagctcccggaagctgcaggcctca</td></tr><tr><td align="left" rowspan="1" colspan="1">P9(59 bp)</td><td align="left" rowspan="1" colspan="1">tacaatgttaccagtccgaagcccacggcctcccgctgcacctgccagggaacaagtc</td></tr><tr><td align="left" rowspan="1" colspan="1">P10(59 bp)</td><td align="left" rowspan="1" colspan="1">gaagcgagctggtcctcggggtgcagggtcccggtgtggggacttgttccctggcaggt</td></tr><tr><td align="left" rowspan="1" colspan="1">P11(59 bp)</td><td align="left" rowspan="1" colspan="1">ccgaggaccagctcgcttcctgccactaccaggcctgccccccgcactcccggagccac</td></tr><tr><td align="left" rowspan="1" colspan="1">P12(59 bp)</td><td align="left" rowspan="1" colspan="1">gaggagcccacatcggggggctggggggccaggattccgggtggctccgggagtgcggg</td></tr><tr><td align="left" rowspan="1" colspan="1">P13(59 bp)</td><td align="left" rowspan="1" colspan="1">cccccgatgtgggctcctcggaccctctgagcatggtgggaccttcccagggccgaagc</td></tr><tr><td align="left" rowspan="1" colspan="1">P14(46 bp)</td><td align="left" rowspan="1" colspan="1">ccgctcgagtcaggaagcgtagctggggcttcggccctgggaaggt</td></tr></tbody></table></div><div id="largeobj_idm139727985106192" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2831817/table/Tab1/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec4" class="sec"><h3 id="Sec4title">Expression and purification of SUMO-FGF21</h3><p id="__p13" class="p p-first">Recombinants were inoculated in fresh Luria-Bertani (LB) medium, and incubated in a shaking incubator at 37&#x000b0;C until the OD<sub>600</sub> was 1.0 to 1.2. Isopropyl -D-thiogalactoside (IPTG) was then added to a final concentration of 1 mM for the induction of expression. Recombinant bacterial cells were collected by centrifugation and lysed by sonication. The supernatants and pellets were collected and subjected to 12% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. The results show that the molecular weight of the expression product is 37 kDa, which corresponds to the predicted size of SUMO-FGF21. The target protein is more than 30% of total cellular protein and the soluble fraction reaches 95.2% of the total expressed recombinant proteins (Figure <a href="/pmc/articles/PMC2831817/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3A</span></span><span>3A</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC2831817/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139727982848832" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig3_HTML.jpg" src="/pmc/articles/PMC2831817/bin/12896_2009_Article_482_Fig3_HTML.jpg" /></div><div id="largeobj_idm139727982848832" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2831817/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC2831817/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p14"><strong>SDS-PAGE analysis of expression and purification of SUMO-FGF21</strong>. Bacterial containing pET-SUMO-FGF21 were induced by IPTG for 3 h or 4 h at 37&#x000b0;C in Figure 3A. The results from the different treatments are shown here. M: protein molecular weight markers;<em>Lane 1</em>: the supernatant of BL21 (DE3) containing pET-SUMO-FGF21 without IPTG;<em>Lane 2</em>: the supernatant of BL21 (DE3) containing pET- SUMO-FGF21 induced with 1 mM IPTG for 3 h; <em>Lane 3</em>: the supernatant of BL21 (DE3) containing pET- SUMO-FGF21 induced with 1 mM IPTG for 4 h; <em>Lane 4</em>: the precipitation of BL21 (DE3) containing pET-SUMO-FGF21 induced with 1 mM IPTG for 4 h. After recombinant bacteria were treated by sonication and centrifugation, the supernatants were loaded on a DEAE sepharose FF and Ni-NTA orderly. The purification results for SUMO-FGF21 are shown in the Figure 3B. <em>Lane1</em>: protein molecular weight marker, <em>Lane2</em>: purified SUMO-FGF21 eluted from Ni-NTA column; <em>Lane3</em>: SUMO-FGF21 eluted from DEAE sepharose FF column.</p></div></div></div><p id="__p15">According to the isoelectric point of fusion protein, DEAE Sepharose FF was chosen for the purification of SUMO-FGF21. SDS-PAGE results show that most of the host proteins are removed from SUMO-FGF21 after being purified with a DEAE Sepharose FF column. Furthermore, a Ni-NTA affinity column was chosen for further purification. Proteins without 6 &#x000d7; His tags were removed from the Ni-NTA resin using PBS containing 10 mM and 20 mM imidazole; SUMO-FGF21 was eluted using PBS containing 300 mM imidazole. SDS-PAGE analysis of samples taken from this step showed that the purity of SUMO-FGF21 reached 96.5% (Figure <a href="/pmc/articles/PMC2831817/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3B</span></span><span>3B</span></a>).</p><p id="__p16" class="p p-last">In recent years, there have been many reports concerning SUMO as an expression fusion tag. The expression level of the fusion protein containing metallothionein, GST and SUMO was 38.4% of the total supernatant proteins from the organism [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014454">18</a>]. Our data show that SUMO-FGF21 concentration is over 25% of all soluble proteins. Expression efficiency may be affected by molecular weight, amino acid constitution, and the function of proteins, etc. As far as protein isolation, we performed two-step purifications, which resulted in the purity of SUMO-FGF21 reaching 96.5%. The results show that two-step purification is helpful for improving the purity of rFGF21, which was more successful than one step Ni-NTA purification [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014444">20</a>], as well as inclusion body purification [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014417">21</a>].</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Cleavage of the SUMO domain from SUMO-FGF21 protein and further purification of rFGF21</h3><p id="__p17" class="p p-first">When the target protein was fused directly to the C-terminus of SUMO, cleavage by SUMO protease 1 resulted in the release of the target protein with the desired N-terminal amino acid sequence[<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014443">16</a>, <a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014468">22</a>]. In our studies, the pre-purified fusion protein was diluted and cleaved by SUMO protease. The lysate was purified by Ni-NTA resin. SUMO and SUMO protease containing His tags that were affiliated by Ni-NTA resin, but rFGF21 was eluted out of the Ni-NTA column. The results showed that rFGF21 was highly purified by SDS-PAGE (Figure <a href="/pmc/articles/PMC2831817/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4A)</span></span><span>4A</span></a>) and could react with the human FGF21 polyclonal antibody by Western blot (Figure <a href="/pmc/articles/PMC2831817/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4B).</span></span><span>4B</span></a>). HPLC analysis of the target protein showed a major peak of rFGF21, with a retention time of 14.984 min; the purity exceeded 96% (Figure <a href="/pmc/articles/PMC2831817/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5</span></span><span>5</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC2831817/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139727986022512" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig4_HTML.jpg" src="/pmc/articles/PMC2831817/bin/12896_2009_Article_482_Fig4_HTML.jpg" /></div><div id="largeobj_idm139727986022512" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2831817/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC2831817/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p18"><strong>SDS-PAGE analysis of SUMO-FGF21 by SUMO protease and rFGF21 assay by Western blot</strong>. The purified SUMO-FGF21 was digested by SUMO protease at 4&#x000b0;C overnight. As seen in Figure 4A, rFGF21 was cut from the SUMO-FGF21 by SUMO protease. <em>Lane1</em>: Protein Molecular Weight Marker. <em>Lane2</em>: purified rFGF21;<em>Lane3</em>: SUMO-FGF21 fusion protein after treatment with SUMO protease. Western blot analysis was performed as described in <em>Materials and Methods</em>. Immunoacitivity of purified rFGF21 with anti-human FGF21 antibody is shown in Figure 4B. <em>Lane1</em>: standard FGF21 (PeproTech Comp.);<em>Lane2</em>: purified rFGF21.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC2831817/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139727986017904" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig5_HTML.jpg" src="/pmc/articles/PMC2831817/bin/12896_2009_Article_482_Fig5_HTML.jpg" /></div><div id="largeobj_idm139727986017904" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2831817/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC2831817/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p19"><strong>HPLC analysis of purified rFGF21</strong>. The purity of rFGF21 eluted from a Ni-NTA sepharose column was further evaluated by HPLC analysis using a C18 column. As seen from the chromatogram, the <em>y</em>-axis indicates the absorbance, while the <em>x</em>-axis represents elution time (min). The main peak observed at 14.984 min corresponds to rFGF21.</p></div></div></div><p id="__p20" class="p p-last">Next, we tested endotoxin levels from three different batches of purified rFGF21, and the results were less than 1.0 EU/ml, which is considered acceptable compared to commercially available proteins. These levels were also in accordance with the standard of injection biologics listed in the Chinese Pharmacopeia of 2005. It also suggests that the purity of rFGF21 by this method can meet the requirements of pharmaceutical research <em>in vivo</em>.</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Mass spectrometric and N-terminal amino acid sequence analysis</h3><p id="__p21" class="p p-first-last">In order to confirm the authenticity of rFGF21, the target protein was subjected to MALDI-TOF mass spectroscopy analysis and N-terminal amino acid sequencing analysis. The molecular weight of rFGF21 analyzed by MALDI-TOF mass spectroscopy was 19.424 kDa, which was very close to 19.411 kDa, theoretical molecular weight of FGF21. Moreover, according to the sequencing result, the first five amino acids of our rFGF21 N-terminus were H-P-I-P-D, which was in conformity with native FGF21.</p></div><div id="Sec7" class="sec sec-last"><h3 id="Sec7title"><em>In vivo</em>bioactivity of rFGF21</h3><p id="__p22" class="p p-first">The construction of diabetic rat models is described in <em>Materials and Methods</em>. We tested the effects of rFGF21 on diabetic rats. Diabetic rats were treated daily for two weeks with high, medium, and low dosages of rFGF21 (150, 300, 600 &#x003bc;g/kg/d). All treatments produced significant changes when compared with the control animals. The statistical results are described using column graph (Figure <a href="/pmc/articles/PMC2831817/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure6).</span></span><span>6</span></a>). We can see that the changes in plasma glucose levels all show significant differences compared to controls after injecting three doses of rFGF21(<sup><em>low</em></sup><em>P</em> &#x0003c; 0.05 vs control, <sup><em>medium</em></sup><em>P</em> &#x0003c; 0.05 vs control, <sup><em>high</em></sup><em>P</em> &#x0003c; 0.01 vs control). The results also show that rFGF21 acts in a dose-dependent manner to reduce plasma glucose in diabetic rats. High doses of rFGF21 result in better effects than the other two doses. The high dose lowers circulating glucose from 20.25 &#x000b1; 5.13 mmol/L to 10.83 &#x000b1; 2.73 mmol/L. Compared to rFGF21, insulin displayed more significant effects in decreasing plasma glucose with <sup><em>c</em></sup><em>P</em> &#x0003c; 0.001, which is considered a significant difference between pre- and post-treatment. The different effects might be due to different mechanism in decreasing plasma glucose between insulin and FGF21. In contrast to insulin, which is known to function via GLUT4 translocation, FGF-21 primarily act through up-regulation of cellular GLUT1[<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014458">23</a>].</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC2831817/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139727984244288" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2009_Article_482_Fig6_HTML.jpg" src="/pmc/articles/PMC2831817/bin/12896_2009_Article_482_Fig6_HTML.jpg" /></div><div id="largeobj_idm139727984244288" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2831817/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC2831817/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Figure 6</a></div><!--caption a7--><div class="caption"><p id="__p23"><strong>The effects of rFGF21 on reducing plasma glucose in diabetic rats</strong>. The STZ treated diabetic rats were injected with different doses of rFGF21 once daily for two weeks. Control: 0.9% NaCl; Low: 0.15 mg/kg rFGF21; Medium: 0.3 mg/kg rFGF21; High: 0.6 mg/kg rFGF21; Insulin: 5U per rat. The results show that rFGF21 acts in a dose-dependent manner to reduce plasma glucose in diabetic rats, with the high dose rFGF21 demonstrating better effects than the other doses. Compared to rFGF21, insulin displays a more significant effect in decreasing plasma glucose. <sup><em>a</em></sup><em>P</em> &#x0003c; 0.05, <sup><em>b</em></sup><em>P</em> &#x0003c; 0.01 and <sup><em>c</em></sup><em>P</em> &#x0003c; 0.001 were considered as the significant difference for post-treatment compared to pre-treatment.</p></div></div></div><p id="__p24" class="p p-last">Many other experiments have also documented that FGF21 could promote the glucose uptake in adipocytes [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014425">6</a>] and 3T3-L1 cells [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014410">5</a>], as well as reduce plasma glucose and triglyceride in animal models of type 2 diabetes, such as mouse and monkey [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014437">20</a>, <a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014442">24</a>]. However, there were some differences in rFGF21-mediated reductions in blood glucose levels attributable to different animal genotypes and treatment. In <em>ob/ob</em> mice, doses of 125 and 750 &#x003bc;g/kg/d of FGF-21 significantly lowered blood glucose compared with vehicle treatment after 3 days of administration[<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014456">5</a>]. After 8 days of drug administration, FGF21 treatment not only reduces fasting blood glucose, but also improves insulin sensitivity in <em>ob</em>/<em>ob</em> mice [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014445">24</a>]. Notably, 100 &#x003bc;g/kg dose of rFGF-21 lowered mean fasting plasma glucose from the overtly diabetic level to near normal when administered for 6 weeks [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014412">10</a>]. In our studies, rFGF21 at doses of 150, 300 or 600 &#x003bc;g/kg/d all decreased glucose levels in diabetic mice. Administration of FGF21 resulted in a dose-dependent reduction in circulating levels of glucose.</p></div></div><div id="Sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec8title">Conclusions</h2><p id="__p25" class="p p-first-last">This study demonstrates that, when fused with SUMO, soluble expression of rFGF21 increased in <em>E. coli</em>; this form is also conveniently isolated rFGF21 than previously described forms. As a novel molecular chaperon domain, SUMO increases the yield of recombinant protein and makes it easier to dissolve in the soluble fraction for protein purification. This strategy can be used as a source of reference for the expression and purification of other proteins.</p></div><div id="Sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec9title">Methods</h2><div id="Sec10" class="sec sec-first"><h3 id="Sec10title">Reagents</h3><p id="__p26" class="p p-first-last"><em>Pyrobest</em><sup>&#x000ae;</sup> DNA Polymerase and restriction enzymes <em>Nde</em>I and <em>Xho</em>I were purchased from TaKaRa Company (Japan). PCR purification kit, gel extraction kit, and plasmid miniprep kit were obtained from the Omega Company (USA). The expression vector pET-3c-SUMO was produced by Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, Jilin Agricultural University (China). DEAE Sepharose FF column and Sepharose G50 column were purchased from GE healthcare (Sweden). Ni-NTA agarose was obtained from Invitrogen (USA). Human FGF21 protein was purchased from the PeproTech Company (Korea), and anti-hFGF21 antibody was purchased from Santa Cruz Biotechnology Company (USA); Dr. Yadong Huang from Ji Nan University graciously supplied us with the SUMO protease.</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">Construction of pET- SUMO-FGF21 recombinant plasmid</h3><p id="__p27" class="p p-first">The strategy for synthesizing the fusion gene is illustrated in Figure <a href="/pmc/articles/PMC2831817/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1.</span></span><span>1</span></a>. The core fragment of SUMO was first obtained by polymerase chain reaction (PCR), which was performed as follows: reaction mixture containing P1, P2, P3, P4, dNTP and 10 &#x000d7; PCR buffer were incubated at 94&#x000b0;C for 4 min. <em>Pyrobest</em><sup>&#x000ae;</sup> DNA polymerase was added to the reaction when the temperature decreased to 55&#x000b0;C. The annealing step was conducted at 55&#x000b0;C for 5 min and elongation was done at 72&#x000b0;C for 60 sec to get fragment A. Likewise, P5, P6, P7, and P8, were reacted to form fragment B; primers P9, P10, P11, and P12 formed fragment C, primers P11, P12, P13, and P14 formed fragment D. Using A and B as the common template, and P1 and P8 as the forward and reverse primers, the reaction was denatured at 94&#x000b0;C for 5 min. This was followed by 30 consecutive cycles of denaturation: 95&#x000b0;C for 30 s, annealing for 30 s at 55&#x000b0;C, extension at 72&#x000b0;C for 1 min, and then a final single extension at 72&#x000b0;C for 7 min to get the fragment M. Fragments C and D were used to create fragment N. Finally, Fragments M and N were used to form the FGF21 fragment, according to the previously described procedure.</p><p id="__p28">Using pET3c-SUMO (plasmid containing SUMO fragment) as template, Pa and the SUMO linker as the forward and reverse primers, the SUMO-linker was generated. Then, using the SUMO-linker and the FGF21 fragment as the common template, Pa and P14 as the forward and reverse primers, the SUMO-FGF21 full-length constructed was created using the same PCR reaction procedure described above.</p><p id="__p29" class="p p-last">The fusion gene was digested with <em>Nde</em>I and <em>Xho</em>I, and then ligated into previously digested pET-20b(+) to create the new expression vector, pET-SUMO-FGF21. Authenticity of the inserted fragment was confirmed by restriction enzyme analysis and automated DNA sequencing.</p></div><div id="Sec12" class="sec"><h3 id="Sec12title">Expression and soluble detection of SUMO-FGF21</h3><p id="__p30" class="p p-first">The recombinant plasmid, pET-SUMO-FGF21 was transformed into <em>Escherichia coli</em> BL21 (DE3) cells. SUMO-FGF21 was expressed as follows: a single transformed colony was grown in 5 ml of LB medium (1% peptone, 1% yeast extract, and 0.5% sodium chloride, pH 7.0) containing 100 &#x003bc;g/ml ampicillin at 37&#x000b0;C with shaking at 250 rpm. After overnight growth, 500 &#x003bc;l of culture was transferred into 50 ml of fresh LB medium for exponential growth. When the OD<sub>600</sub> value reached 0.6, isopropyl-&#x003b2;-D-thiogalactopyranoside (IPTG) was added to the culture at a final concentration of 1 mmol/L. The culture was then incubated for another 4 hours at 37&#x000b0;C with shaking at 220 rpm. SUMO-FGF21 was separated by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and the amount of fusion protein yield was measured by densitometer scanning.</p><p id="__p31" class="p p-last">Cell medium induced under different conditions was harvested by centrifugation at 8000 rpm for 5 min. Cell pellets were suspended into 20 mmol/L PBS buffer and dissolved by sonication. The suspensions were centrifuged at 18,000 rpm for 30 min at 4&#x000b0;C. The clear supernatant was collected (soluble fraction) and the remaining pellets (insoluble fraction) containing inclusion bodies were resuspended into an equal volume of lysis buffer. Both soluble and insoluble fractions were analyzed by 12% SDS-PAGE.</p></div><div id="Sec13" class="sec"><h3 id="Sec13title">Purification of SUMO-FGF21</h3><p id="__p32" class="p p-first-last">The cell lysate was purified by DEAE-Sepharose FF column chromatography. SUMO-FGF21 was eluated with buffer containing different concentrations of NaCl (100-300 mmol/L, pH 9.0), followed by further purification with Ni-NTA resin (Invitrogen). The Ni-NTA resin was washed with wash buffer I (20 mmol/L PBS containing 10 mM imidazole and 150 mM NaCl, pH 8.0) until OD<sub>280</sub> of effluent reached base line. Contaminating proteins were eluted from the column with wash buffer II (20 mmol/L PBS containing 20 mM imidazole and 150 mM NaCl, pH 8.0). Finally, 6 &#x000d7; His-tagged SUMO-FGF21 protein was collected from the column with elution buffer (20 mmol/L PBS containing 300 mM imidazole and 150 mM NaCl, pH 8.0). Samples taken at the elution peak were pooled. The purity of SUMO-FGF21 was assessed using SDS-PAGE and the concentration was evaluated by the Bradford method.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Cleavage of SUMO from SUMO-FGF21 and purification of rFGF21</h3><p id="__p33" class="p p-first-last">The eluted fusion protein was diluted to a concentration of 1 mg/ml. Ten unit of SUMO protease were added to the dilution and the mixture was incubated in high salt buffer (50 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 1 mM DTT) for 1 hr at 4&#x000b0;C. Following incubation, the mixture was loaded onto an Ni-NTA resin column to obtain the rFGF21, which was further concentrated by ultrafiltration at 4&#x000b0;C. The SUMO, SUMO-FGF21 and SUMO protease stayed bound to the Ni-NTA resin and only rFGF21 was eluted from the column when washed off the resin with elution buffer. rFGF21 was then desalted with Sepharose G50 column.</p></div><div id="Sec15" class="sec"><h3 id="Sec15title">The authenticity assay for rFGF21</h3><p id="__p34" class="p p-first">The immunogenic activity of purified rFGF21 was assayed by Western blotting. Total cellular protein was boiled in an equal volume of sample loading buffer, a Tris-HCl buffer (pH 6.8) containing 20% glycerol, 2.5% SDS, 10% &#x003b2;-Mercaptoethanol and 0.005% bromophenol blue. Protein samples were electrophoresed on 12% polyacrylamide gels containing SDS. Proteins were electrophoretically transferred onto PVDF membranes, and after overnight exposure to 3% BSA to block nonspecific binding, the membranes were incubated with a polyclonal FGF21 antibody (Santa Cruz Biotechnology Inc, 1:1000). The membranes were washed and incubated with a 1:5000 dilution of secondary HRP-conjugated antibody (rabbit anti-goat IgG, Amersham Biosciences Corp.). Immunoreactive bands were visualized using a DAB kit (Boshide Inc, Wuhan, China).</p><p id="__p35" class="p p-last">For high performance liquid chromatography (HPLC) analysis, purified rFGF21 was desalted and then loaded onto a C18 column. The elution was carried out using a linear gradient of 30-70% acetonitrile at a flow rate of 0.8 ml/min in the presence of 0.1% trifluoroacetic acid (TFA). The fractions containing rFGF21 were pooled and subjected to N-terminal amino acid sequencing, amino acid composition analysis and MALDI-TOF mass spectroscopy analysis. The concentration of rFGF21 was evaluated by the Bradford method.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">Endotoxin assay</h3><p id="__p36" class="p p-first-last">The endotoxin concentration of rFGF21 was estimated quantitatively using the Chromogenic Tachypleus Amebocyte Lysate (TAL) endpoint assay kit as described by the manufacturer (Zhanjiang A&#x00026;C Biological Ltd, China). The assay was performed according to the kit protocol.</p></div><div id="Sec17" class="sec"><h3 id="Sec17title"><em>In vivo</em>activity assay of rFGF21</h3><p id="__p37" class="p p-first-last">All procedures involving animals and their care described here were approved by the Institutional Animal Care and Use Committee of Jilin Agricultural University and were performed in accordance with institutional guidelines for animal experiments. Male Wistar adult rats (weighting at 180-220 g) were randomly divided into the high fat diet group (HFD, <em>n</em> = 40) and the common diet group (NC, <em>n</em> = 8) after being fed a high fat diet for two months. HFD group animals were given peritoneal injections of 35 mg/kg streptozotocin (STZ, Sigma, USA), while the NC group was given an equivalent volume of citric acid buffer. One week later, blood was collected and the fasting plasma glucose (FPG) was assayed. STZ treated rats with FPG = 11.1 mmol/L were chosen as type 2 diabetes models (<em>n</em> = 40). Subsequently, 32 diabetic rats were divided into five groups (n = 8/group): 1) the diabetic rats treated with a 0.6 mg/kg of rFGF21 group (high dose); 2) diabetic rats treated with a 0.3 mg/kg of rFGF21 group (medium dose); 3) diabetic rats treated with a 0.15 mg/kg of rFGF21 group (low dose); 4) diabetic rats treated with insulin (5 U/day) group (positive control) and 5) diabetic rats treated with 0.9% NaCl group (negative control). In addition, the 8 NC rats constituted the blank control group. Drugs were given by subcutaneous injection once daily for two weeks.</p></div><div id="Sec18" class="sec sec-last"><h3 id="Sec18title">Statistical analysis</h3><p id="__p38" class="p p-first-last">Values are expressed as means &#x000b1; S.E.M. Mean Value Comparisons between two groups were performed using the <em>Student t test</em>. Significant differences were considered at <em>P</em> &#x0003c; 0.05.</p></div></div><div id="idm139727986059856" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139727986059856title">Acknowledgements</h2><div class="sec"><p id="__p51">We appreciate the support of Jilin Agricultural University\'s doctoral fund (2007013), the scientific fund of Jilin province (2008712) and the scientific fund of Wenzhou (Y20090015).</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec19" class="sec sec-first"><h3 id="Sec19title">Authors&#x02019; original submitted files for images</h3><p id="__p39" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC2831817/bin/12896_2009_482_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(21K, pdf)</sup></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC2831817/bin/12896_2009_482_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(24K, pdf)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC2831817/bin/12896_2009_482_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(49K, pdf)</sup></span><span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC2831817/bin/12896_2009_482_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(18K, pdf)</sup></span><span class="sup-box" id="MOESM5"><a href="/pmc/articles/PMC2831817/bin/12896_2009_482_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 5</a><sup>(29K, pdf)</sup></span><span class="sup-box" id="MOESM6"><a href="/pmc/articles/PMC2831817/bin/12896_2009_482_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 6</a><sup>(15K, pdf)</sup></span></p></div></div><div id="idm139727986064336" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139727986064336title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139727986064208"><p id="__p46" class="p p-first-last">Yechen Xiao contributed equally to this work.</p></p><p class="fn sec" id="idm139727986063584"><p id="__p47" class="p p-first"><strong>Competing interests</strong></p><p id="__p48" class="p p-last">The authors declare that they have no competing interests.</p></p><p class="fn sec" id="idm139727986062336"><p id="__p49" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p50" class="p p-last">HYW performed the main experiments of this project, including rFGF21 purification, immunoblot assay and activity analysis. YCX conceived the idea, directed the graduate student and drafted the manuscript. LJF and HXZ participated in the purification of rFGF21. YFZ participated in the cloning of the fusion gene and constructing the expression plasmid. XSW and HCG performed <em>in vivo</em> activity assay of rFGF21. YDH supported the SUMO protease and revised the manuscript. XKL, as the Principal Investigator of the project, revised the manuscript. All authors have read and approved the manuscript.</p></p></div></div><div id="idm139728024756000aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139728024756000aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Huiyan Wang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.oohay@nayiuh_w" class="oemail">nc.moc.oohay@nayiuh_w</a></span>.</p><p><span class="fm-affl">Yechen Xiao, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@oaixnehcey" class="oemail">moc.oohay@oaixnehcey</a></span>.</p><p><span class="fm-affl">Lianjun Fu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.361@8691nujnailuf" class="oemail">moc.361@8691nujnailuf</a></span>.</p><p><span class="fm-affl">Hongxin Zhao, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.361@nix.gnohoahz" class="oemail">moc.361@nix.gnohoahz</a></span>.</p><p><span class="fm-affl">Yaofang Zhang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.621@ffgnafoaygnahz" class="oemail">moc.621@ffgnafoaygnahz</a></span>.</p><p><span class="fm-affl">Xiaoshan Wan, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@7020eunitnoc" class="oemail">moc.liamtoh@7020eunitnoc</a></span>.</p><p><span class="fm-affl">Yuxia Qin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.621@liameaixuy" class="oemail">moc.621@liameaixuy</a></span>.</p><p><span class="fm-affl">Yadong Huang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.621@4002gnauhdy" class="oemail">moc.621@4002gnauhdy</a></span>.</p><p><span class="fm-affl">Hongchang Gao, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@72choag" class="oemail">moc.liamg@72choag</a></span>.</p><p><span class="fm-affl">Xiaokun Li, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.361@ilnukoaix" class="oemail">ten.361@ilnukoaix</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Muise ES, Azzolina B, Kuo DW, El-Sherbeini M, Tan Y, Yuan X, Mu J, Thompson JR, Berger JP, Wong KK. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. <span><span class="ref-journal">Mol Pharmacol. </span>2008;<span class="ref-vol">74</span>(2):403\xe2\x80\x93412. doi: 10.1124/mol.108.044826.</span> [<a href="/pubmed/18467542" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1124%2Fmol.108.044826" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=Adipose+fibroblast+growth+factor+21+is+up-regulated+by+peroxisome+proliferator-activated+receptor+gamma+and+altered+metabolic+states&amp;author=ES+Muise&amp;author=B+Azzolina&amp;author=DW+Kuo&amp;author=M+El-Sherbeini&amp;author=Y+Tan&amp;volume=74&amp;issue=2&amp;publication_year=2008&amp;pages=403-412&amp;pmid=18467542&amp;doi=10.1124/mol.108.044826&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. <span><span class="ref-journal">Biochim Biophys Acta. </span>2000;<span class="ref-vol">1492</span>(1):203\xe2\x80\x93206. doi: 10.1016/S0167-4781(00)00067-1.</span> [<a href="/pubmed/10858549" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0167-4781(00)00067-1" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=Identification+of+a+novel+FGF,+FGF-21,+preferentially+expressed+in+the+liver&amp;author=T+Nishimura&amp;author=Y+Nakatake&amp;author=M+Konishi&amp;author=N+Itoh&amp;volume=1492&amp;issue=1&amp;publication_year=2000&amp;pages=203-206&amp;pmid=10858549&amp;doi=10.1016/S0167-4781(00)00067-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, et al.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. <span><span class="ref-journal">Cell Metab. </span>2007;<span class="ref-vol">5</span>(6):415\xe2\x80\x93425. doi: 10.1016/j.cmet.2007.05.003.</span> [<a href="/pubmed/17550777" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.cmet.2007.05.003" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=Endocrine+regulation+of+the+fasting+response+by+PPARalpha-mediated+induction+of+fibroblast+growth+factor+21&amp;author=T+Inagaki&amp;author=P+Dutchak&amp;author=G+Zhao&amp;author=X+Ding&amp;author=L+Gautron&amp;volume=5&amp;issue=6&amp;publication_year=2007&amp;pages=415-425&amp;pmid=17550777&amp;doi=10.1016/j.cmet.2007.05.003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro-o M. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>(37):26687\xe2\x80\x9326695. doi: 10.1074/jbc.M704165200.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2496965/">PMC free article</a>]</span> [<a href="/pubmed/17623664" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1074%2Fjbc.M704165200" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Tissue-specific+expression+of+betaKlotho+and+fibroblast+growth+factor+(FGF)+receptor+isoforms+determines+metabolic+activity+of+FGF19+and+FGF21&amp;author=H+Kurosu&amp;author=M+Choi&amp;author=Y+Ogawa&amp;author=AS+Dickson&amp;author=R+Goetz&amp;volume=282&amp;issue=37&amp;publication_year=2007&amp;pages=26687-26695&amp;pmid=17623664&amp;doi=10.1074/jbc.M704165200&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, et al.  FGF-21 as a novel metabolic regulator. <span><span class="ref-journal">J Clin Invest. </span>2005;<span class="ref-vol">115</span>(6):1627\xe2\x80\x931635. doi: 10.1172/JCI23606.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1088017/">PMC free article</a>]</span> [<a href="/pubmed/15902306" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1172%2FJCI23606" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=FGF-21+as+a+novel+metabolic+regulator&amp;author=A+Kharitonenkov&amp;author=TL+Shiyanova&amp;author=A+Koester&amp;author=AM+Ford&amp;author=R+Micanovic&amp;volume=115&amp;issue=6&amp;publication_year=2005&amp;pages=1627-1635&amp;pmid=15902306&amp;doi=10.1172/JCI23606&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Wente W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, Sandusky GE, Sewing S, Treinies I, Zitzer H, Gromada J. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. <span><span class="ref-journal">Diabetes. </span>2006;<span class="ref-vol">55</span>(9):2470\xe2\x80\x932478. doi: 10.2337/db05-1435.</span> [<a href="/pubmed/16936195" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2337%2Fdb05-1435" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Fibroblast+growth+factor-21+improves+pancreatic+beta-cell+function+and+survival+by+activation+of+extracellular+signal-regulated+kinase+1/2+and+Akt+signaling+pathways&amp;author=W+Wente&amp;author=AM+Efanov&amp;author=M+Brenner&amp;author=A+Kharitonenkov&amp;author=A+Koster&amp;volume=55&amp;issue=9&amp;publication_year=2006&amp;pages=2470-2478&amp;pmid=16936195&amp;doi=10.2337/db05-1435&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Huang X, Yu C, Jin C, Yang C, Xie R, Cao D, Wang F, McKeehan WL. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis. <span><span class="ref-journal">Mol Carcinog. </span>2006;<span class="ref-vol">45</span>(12):934\xe2\x80\x93942. doi: 10.1002/mc.20241.</span> [<a href="/pubmed/16929488" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fmc.20241" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Carcinog&amp;title=Forced+expression+of+hepatocyte-specific+fibroblast+growth+factor+21+delays+initiation+of+chemically+induced+hepatocarcinogenesis&amp;author=X+Huang&amp;author=C+Yu&amp;author=C+Jin&amp;author=C+Yang&amp;author=R+Xie&amp;volume=45&amp;issue=12&amp;publication_year=2006&amp;pages=934-942&amp;pmid=16929488&amp;doi=10.1002/mc.20241&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Ornitz DM, Itoh N. Fibroblast growth factors. <span><span class="ref-journal">Genome Biol. </span>2001;<span class="ref-vol">2</span>(3):REVIEWS3005. doi: 10.1186/gb-2001-2-3-reviews3005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC138918/">PMC free article</a>]</span> [<a href="/pubmed/11276432" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2Fgb-2001-2-3-reviews3005" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Biol&amp;title=Fibroblast+growth+factors&amp;author=DM+Ornitz&amp;author=N+Itoh&amp;volume=2&amp;issue=3&amp;publication_year=2001&amp;pages=REVIEWS3005&amp;pmid=11276432&amp;doi=10.1186/gb-2001-2-3-reviews3005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Nicholes K, Guillet S, Tomlinson E, Hillan K, Wright B, Frantz GD, Pham TA, Dillard-Telm L, Tsai SP, Stephan JP, et al.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. <span><span class="ref-journal">Am J Pathol. </span>2002;<span class="ref-vol">160</span>(6):2295\xe2\x80\x932307. doi: 10.1016/S0002-9440(10)61177-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1850847/">PMC free article</a>]</span> [<a href="/pubmed/12057932" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0002-9440(10)61177-7" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;title=A+mouse+model+of+hepatocellular+carcinoma:+ectopic+expression+of+fibroblast+growth+factor+19+in+skeletal+muscle+of+transgenic+mice&amp;author=K+Nicholes&amp;author=S+Guillet&amp;author=E+Tomlinson&amp;author=K+Hillan&amp;author=B+Wright&amp;volume=160&amp;issue=6&amp;publication_year=2002&amp;pages=2295-2307&amp;pmid=12057932&amp;doi=10.1016/S0002-9440(10)61177-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB, Etgen GJ. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. <span><span class="ref-journal">Endocrinology. </span>2007;<span class="ref-vol">148</span>(2):774\xe2\x80\x93781. doi: 10.1210/en.2006-1168.</span> [<a href="/pubmed/17068132" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1210%2Fen.2006-1168" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=The+metabolic+state+of+diabetic+monkeys+is+regulated+by+fibroblast+growth+factor-21&amp;author=A+Kharitonenkov&amp;author=VJ+Wroblewski&amp;author=A+Koester&amp;author=YF+Chen&amp;author=CK+Clutinger&amp;volume=148&amp;issue=2&amp;publication_year=2007&amp;pages=774-781&amp;pmid=17068132&amp;doi=10.1210/en.2006-1168&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Johnson ES. Protein modification by SUMO. <span><span class="ref-journal">Annu Rev Biochem. </span>2004;<span class="ref-vol">73</span>:355\xe2\x80\x93382. doi: 10.1146/annurev.biochem.73.011303.074118.</span> [<a href="/pubmed/15189146" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1146%2Fannurev.biochem.73.011303.074118" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Biochem&amp;title=Protein+modification+by+SUMO&amp;author=ES+Johnson&amp;volume=73&amp;publication_year=2004&amp;pages=355-382&amp;pmid=15189146&amp;doi=10.1146/annurev.biochem.73.011303.074118&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Zhou F, Xue Y, Lu H, Chen G, Yao X. A genome-wide analysis of sumoylation-related biological processes and functions in human nucleus. <span><span class="ref-journal">FEBS Lett. </span>2005;<span class="ref-vol">579</span>(16):3369\xe2\x80\x933375. doi: 10.1016/j.febslet.2005.04.076.</span> [<a href="/pubmed/15922331" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.febslet.2005.04.076" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=A+genome-wide+analysis+of+sumoylation-related+biological+processes+and+functions+in+human+nucleus&amp;author=F+Zhou&amp;author=Y+Xue&amp;author=H+Lu&amp;author=G+Chen&amp;author=X+Yao&amp;volume=579&amp;issue=16&amp;publication_year=2005&amp;pages=3369-3375&amp;pmid=15922331&amp;doi=10.1016/j.febslet.2005.04.076&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Butt TR, Edavettal SC, Hall JP, Mattern MR. SUMO fusion technology for difficult-to-express proteins. <span><span class="ref-journal">Protein Expr Purif. </span>2005;<span class="ref-vol">43</span>(1):1\xe2\x80\x939. doi: 10.1016/j.pep.2005.03.016.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7129290/">PMC free article</a>]</span> [<a href="/pubmed/16084395" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.pep.2005.03.016" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Expr+Purif&amp;title=SUMO+fusion+technology+for+difficult-to-express+proteins&amp;author=TR+Butt&amp;author=SC+Edavettal&amp;author=JP+Hall&amp;author=MR+Mattern&amp;volume=43&amp;issue=1&amp;publication_year=2005&amp;pages=1-9&amp;pmid=16084395&amp;doi=10.1016/j.pep.2005.03.016&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Sun Z, Xia Z, Bi F, Liu JN. Expression and purification of human urodilatin by small ubiquitin-related modifier fusion in Escherichia coli. <span><span class="ref-journal">Appl Microbiol Biotechnol. </span>2008;<span class="ref-vol">78</span>(3):495\xe2\x80\x93502. doi: 10.1007/s00253-007-1330-0.</span> [<a href="/pubmed/18189135" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs00253-007-1330-0" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Appl+Microbiol+Biotechnol&amp;title=Expression+and+purification+of+human+urodilatin+by+small+ubiquitin-related+modifier+fusion+in+Escherichia+coli&amp;author=Z+Sun&amp;author=Z+Xia&amp;author=F+Bi&amp;author=JN+Liu&amp;volume=78&amp;issue=3&amp;publication_year=2008&amp;pages=495-502&amp;pmid=18189135&amp;doi=10.1007/s00253-007-1330-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Zuo X, Mattern MR, Tan R, Li S, Hall J, Sterner DE, Shoo J, Tran H, Lim P, Sarafianos SG, et al.  Expression and purification of SARS coronavirus proteins using SUMO-fusions. <span><span class="ref-journal">Protein Expr Purif. </span>2005;<span class="ref-vol">42</span>(1):100\xe2\x80\x93110. doi: 10.1016/j.pep.2005.02.004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7129641/">PMC free article</a>]</span> [<a href="/pubmed/15939295" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.pep.2005.02.004" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Expr+Purif&amp;title=Expression+and+purification+of+SARS+coronavirus+proteins+using+SUMO-fusions&amp;author=X+Zuo&amp;author=MR+Mattern&amp;author=R+Tan&amp;author=S+Li&amp;author=J+Hall&amp;volume=42&amp;issue=1&amp;publication_year=2005&amp;pages=100-110&amp;pmid=15939295&amp;doi=10.1016/j.pep.2005.02.004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Marblestone JG, Edavettal SC, Lim Y, Lim P, Zuo X, Butt TR. Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO. <span><span class="ref-journal">Protein Sci. </span>2006;<span class="ref-vol">15</span>(1):182\xe2\x80\x93189. doi: 10.1110/ps.051812706.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2242369/">PMC free article</a>]</span> [<a href="/pubmed/16322573" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1110%2Fps.051812706" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Sci&amp;title=Comparison+of+SUMO+fusion+technology+with+traditional+gene+fusion+systems:+enhanced+expression+and+solubility+with+SUMO&amp;author=JG+Marblestone&amp;author=SC+Edavettal&amp;author=Y+Lim&amp;author=P+Lim&amp;author=X+Zuo&amp;volume=15&amp;issue=1&amp;publication_year=2006&amp;pages=182-189&amp;pmid=16322573&amp;doi=10.1110/ps.051812706&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Su Z, Huang Y, Zhou Q, Wu Z, Wu X, Zheng Q, Ding C, Li X. High-level expression and purification of human epidermal growth factor with SUMO fusion in Escherichia coli. <span><span class="ref-journal">Protein Pept Lett. </span>2006;<span class="ref-vol">13</span>(8):785\xe2\x80\x93792. doi: 10.2174/092986606777841280.</span> [<a href="/pubmed/17073723" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2174%2F092986606777841280" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Pept+Lett&amp;title=High-level+expression+and+purification+of+human+epidermal+growth+factor+with+SUMO+fusion+in+Escherichia+coli&amp;author=Z+Su&amp;author=Y+Huang&amp;author=Q+Zhou&amp;author=Z+Wu&amp;author=X+Wu&amp;volume=13&amp;issue=8&amp;publication_year=2006&amp;pages=785-792&amp;pmid=17073723&amp;doi=10.2174/092986606777841280&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Huang Y, Su Z, Li Y, Zhang Q, Cui L, Su Y, Ding C, Zhang M, Feng C, Tan Y, et al.  Expression and Purification of glutathione transferase-small ubiquitin-related modifier-metallothionein fusion protein and its neuronal and hepatic protection against D-galactose-induced oxidative damage in mouse model. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2009;<span class="ref-vol">329</span>(2):469\xe2\x80\x93478. doi: 10.1124/jpet.108.149401.</span> [<a href="/pubmed/19208897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1124%2Fjpet.108.149401" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Expression+and+Purification+of+glutathione+transferase-small+ubiquitin-related+modifier-metallothionein+fusion+protein+and+its+neuronal+and+hepatic+protection+against+D-galactose-induced+oxidative+damage+in+mouse+model&amp;author=Y+Huang&amp;author=Z+Su&amp;author=Y+Li&amp;author=Q+Zhang&amp;author=L+Cui&amp;volume=329&amp;issue=2&amp;publication_year=2009&amp;pages=469-478&amp;pmid=19208897&amp;doi=10.1124/jpet.108.149401&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Wu X, Nie C, Huang Z, Nie Y, Yan Q, Xiao Y, Su Z, Huang Y, Xiao J, Zeng Y, et al.  Expression and purification of human keratinocyte growth factor 2 by fusion with SUMO. <span><span class="ref-journal">Mol Biotechnol. </span>2009;<span class="ref-vol">42</span>(1):68\xe2\x80\x9374. doi: 10.1007/s12033-008-9135-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7090735/">PMC free article</a>]</span> [<a href="/pubmed/19104760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs12033-008-9135-7" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biotechnol&amp;title=Expression+and+purification+of+human+keratinocyte+growth+factor+2+by+fusion+with+SUMO&amp;author=X+Wu&amp;author=C+Nie&amp;author=Z+Huang&amp;author=Y+Nie&amp;author=Q+Yan&amp;volume=42&amp;issue=1&amp;publication_year=2009&amp;pages=68-74&amp;pmid=19104760&amp;doi=10.1007/s12033-008-9135-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Ren GP, Hou YT, Jiang YY, Li JN, Zhang W, Di L, Li DS. [Efficient expression of soluble human FGF-21 and its glucose regulation activity] <span><span class="ref-journal">Yao Xue Xue Bao. </span>2009;<span class="ref-vol">44</span>(5):548\xe2\x80\x93552.</span> [<a href="/pubmed/19618734" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Yao+Xue+Xue+Bao&amp;title=[Efficient+expression+of+soluble+human+FGF-21+and+its+glucose+regulation+activity]&amp;author=GP+Ren&amp;author=YT+Hou&amp;author=YY+Jiang&amp;author=JN+Li&amp;author=W+Zhang&amp;volume=44&amp;issue=5&amp;publication_year=2009&amp;pages=548-552&amp;pmid=19618734&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, et al.  Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. <span><span class="ref-journal">Diabetes. </span>2009;<span class="ref-vol">58</span>(1):250\xe2\x80\x93259. doi: 10.2337/db08-0392.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2606881/">PMC free article</a>]</span> [<a href="/pubmed/18840786" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2337%2Fdb08-0392" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Fibroblast+growth+factor+21+reverses+hepatic+steatosis,+increases+energy+expenditure,+and+improves+insulin+sensitivity+in+diet-induced+obese+mice&amp;author=J+Xu&amp;author=DJ+Lloyd&amp;author=C+Hale&amp;author=S+Stanislaus&amp;author=M+Chen&amp;volume=58&amp;issue=1&amp;publication_year=2009&amp;pages=250-259&amp;pmid=18840786&amp;doi=10.2337/db08-0392&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD, Butt TR. SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. <span><span class="ref-journal">J Struct Funct Genomics. </span>2004;<span class="ref-vol">5</span>(1-2):75\xe2\x80\x9386. doi: 10.1023/B:JSFG.0000029237.70316.52.</span> [<a href="/pubmed/15263846" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1023%2FB%3AJSFG.0000029237.70316.52" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Struct+Funct+Genomics&amp;title=SUMO+fusions+and+SUMO-specific+protease+for+efficient+expression+and+purification+of+proteins&amp;author=MP+Malakhov&amp;author=MR+Mattern&amp;author=OA+Malakhova&amp;author=M+Drinker&amp;author=SD+Weeks&amp;volume=5&amp;issue=1-2&amp;publication_year=2004&amp;pages=75-86&amp;pmid=15263846&amp;doi=10.1023/B:JSFG.0000029237.70316.52&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Elghazi L, Cras-Meneur C, Czernichow P, Scharfmann R. Role for FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell proliferation. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2002;<span class="ref-vol">99</span>(6):3884\xe2\x80\x933889. doi: 10.1073/pnas.062321799.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC122618/">PMC free article</a>]</span> [<a href="/pubmed/11891329" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.062321799" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Role+for+FGFR2IIIb-mediated+signals+in+controlling+pancreatic+endocrine+progenitor+cell+proliferation&amp;author=L+Elghazi&amp;author=C+Cras-Meneur&amp;author=P+Czernichow&amp;author=R+Scharfmann&amp;volume=99&amp;issue=6&amp;publication_year=2002&amp;pages=3884-3889&amp;pmid=11891329&amp;doi=10.1073/pnas.062321799&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Berglund ED, Li CY, Bina HA, Lynes SE, Michael MD, Shanafelt AB, Kharitonenkov A, Wasserman DH. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. <span><span class="ref-journal">Endocrinology. </span>2009;<span class="ref-vol">150</span>(9):4084\xe2\x80\x934093. doi: 10.1210/en.2009-0221.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2736088/">PMC free article</a>]</span> [<a href="/pubmed/19470704" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1210%2Fen.2009-0221" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Fibroblast+growth+factor+21+controls+glycemia+via+regulation+of+hepatic+glucose+flux+and+insulin+sensitivity&amp;author=ED+Berglund&amp;author=CY+Li&amp;author=HA+Bina&amp;author=SE+Lynes&amp;author=MD+Michael&amp;volume=150&amp;issue=9&amp;publication_year=2009&amp;pages=4084-4093&amp;pmid=19470704&amp;doi=10.1210/en.2009-0221&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2831817&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2831817/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2831817/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2831817/pdf/12896_2009_Article_482.pdf">PDF (1012K)</a></li> | <li><a href="#" data-citationid="PMC2831817" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2831817%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2831817%2F&amp;text=High-level%20expression%20and%20purification%20of%20soluble%20recombinant%20FGF21%20protein%20by%20SUMO%20fusion%20in%20Escherichia%20coli"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2831817%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="20163718" data-aiid="7091211" data-aid="2831817" data-iid="354737" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2831817" data-md5="a4a12aa12f1ceae835b43691526507e5"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:33:12-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B943DE9A435B100000000037B037B&amp;ncbi_session=8A1B943DE9A4AC81_0891SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2831817%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2831817/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B943DE9A4AC81_0891SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'